TEPODITAMAB
UNII LK0H7J2V3C

Substance Identification & Data

This profile provides standardized clinical and technical data for Tepoditamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LK0H7J2V3C.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2044679-53-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

LK0H7J2V3C

CAS Registry Number

2044679-53-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TEPODITAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C148141

National Cancer Institute reference terminology for clinical and research data.

INN ID

10766

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tepoditamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TEPODITAMAB

Common Names & Synonyms

ANTI-CLEC12A/CD3 BISPECIFIC ANTIBODY MCLA117

IMMUNOGLOBULIN G1, BISPECIFIC, ANTI-(C-TYPE LECTIN CLEC12A AND CD3 ANTIGEN) (HUMAN MONOCLONAL MCLA-117 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MCLA-117 .KAPPA.-CHAIN, DIMER

TEPODITAMAB [INN]